Format

Send to

Choose Destination
J Med Chem. 1999 Dec 16;42(25):5061-3.

Discovery of the first potent and selective small molecule opioid receptor-like (ORL1) antagonist: 1-[(3R,4R)-1-cyclooctylmethyl-3- hydroxymethyl-4-piperidyl]-3-ethyl-1, 3-dihydro-2H-benzimidazol-2-one (J-113397).

Author information

1
Banyu Tsukuba Research Institute in collaboration with Merck Research Laboratories, Banyu Pharmaceutical Company Ltd., Okubo 3, Tsukuba, Ibaraki 300-2611, Japan.
PMID:
10602690
DOI:
10.1021/jm990517p
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center